These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24763884)

  • 1. Identified differently expressed genes in renal cell carcinoma by using multiple microarray datasets running head: differently expressed genes in renal cell carcinoma.
    Cheng Y; Hong M; Cheng B
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1033-40. PubMed ID: 24763884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differently expressed genes in leukemia using multiple microarray datasets.
    Zhang ZY; Xu RQ; Guo TJ; Zhang M; Li DX; Lu XY
    Genet Mol Res; 2014 Dec; 13(4):10482-9. PubMed ID: 25511031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of feature genes of the renal cell carcinoma with DNA microarray.
    Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
    Liu F; Li H; Chang H; Wang J; Lu J
    Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
    Liu Z; Lu Y; He Z; Chen L; Lu Y
    Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
    Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
    Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal gene expression profile reveals the common key signatures associated with clear cell renal cell carcinoma: a meta-analysis.
    Zhang HJ; Sun ZQ; Qian WQ; Sheng L
    Genet Mol Res; 2015 Mar; 14(1):2216-24. PubMed ID: 25867368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
    Liu X; Wang J; Sun G
    Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
    Zhai W; Xu YF; Liu M; Zheng JH
    J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
    Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
    Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
    Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
    Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Bi D; Ning H; Liu S; Que X; Ding K
    Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
    Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
    Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression network analysis of differentially expressed genes associated with metastasis in prolactin pituitary tumors.
    Zhang W; Zang Z; Song Y; Yang H; Yin Q
    Mol Med Rep; 2014 Jul; 10(1):113-8. PubMed ID: 24736764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses.
    Zhang W; Xu Y; Zhang J; Wu J
    Biomed Res Int; 2020; 2020():2671281. PubMed ID: 32090070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.